Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imatinib in the treatment of solid tumours.

Targeted oncology - 1 Jan 2009

Duffaud Florence, Le Cesne Axel

Abstract excerpt

The extraordinary success of imatinib in gastrointestinal stromal tumors (GIST) represents a model for molecularly targeted therapy for other solid tumors. Research is currently going to identify the molecular basis of mechanisms of action and drug resistance. In this article, we review recent advances in the clinical management of patients with GISTs treated with imatinib, but also of patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Benzamides
Share to Desmoid Tumors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to Gastrointestinal Stromal Tumors

Share to Imatinib Mesylate

Share to Receptor, Macrophage Colony-Stimulating Factor

Share to Receptors, Platelet-Derived Growth Factor

Source

Identifiers

PMID: 19343301
DOI: 10.1007/s11523-008-0101-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imatinib in the treatment of solid tumours.PMID 19343301Read ↗

Novel treatment targets in sarcoma: more than just the GIST.Semantic proximity Read ↗

Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.Semantic proximity Read ↗

Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.Semantic proximity Read ↗

Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.Semantic proximity Read ↗

Genetic Aberrations in Imatinib-Resistant Dermatofibrosarcoma Protuberans Revealed by Whole Genome SequencingSemantic proximity Read ↗

Treatment of gastrointestinal stromal tumor after imatinib and sunitinib.Semantic proximity Read ↗

Gastrointestinal stromal tumors: who should get imatinib and for how long?Semantic proximity Read ↗

Targeting oncogene dependence and resistance.Semantic proximity Read ↗

Bench to Bedside and Back Again: Personalizing Treatment for Patients with GISTSemantic proximity Read ↗

Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor.Semantic proximity Read ↗

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.Semantic proximity Read ↗

[GIST refractory to imatinib treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.